Waiting for quick correctionConfirming with volume the breakout of the trend ceiling, we can expect a correction, buy calls with a strike price of 153 OM only after confirmation
NTRA trade ideas
NTRA Institutional trade analysisKey Insights:
1. Institutional Support:
• Renowned investor Stan Druckenmiller has increased his position in Natera by 80%, making it his largest position. This reflects strong institutional confidence in the company and adds a significant bullish sentiment to the stock’s outlook.
• Institutional buying of this magnitude often acts as a catalyst for sustained price momentum, attracting other investors.
2. Trend Analysis:
• The stock is in a strong uptrend, marked by a series of higher highs and higher lows.
• The break above the critical resistance zone (now support at $154.65 and $143.15) reinforces the bullish case, supported by high volume.
3. Technical Indicators:
• Moving Averages: The price is well above the 13, 48, and 200 EMAs, confirming bullish momentum.
• RSI (77.73): Overbought conditions indicate a potential pullback or consolidation before the next move upward, which is typical during strong uptrends.
4. Volume Confirmation:
• Recent volume spikes align with the breakout above $154.65, suggesting strong buying interest and confirming the breakout’s validity.
Key Levels to Watch:
1. Support Levels:
• $154.65: Immediate support and a potential entry point for a pullback trade.
• $143.15: Secondary support zone aligning with prior resistance.
• $131.93: Long-term support and the trendline’s base, critical for maintaining the bullish structure.
2. Resistance Levels:
• $171.95: Immediate resistance and the recent high. A breakout above this level would confirm continuation of the uptrend.
• $190-$200: Next target zone based on psychological resistance and potential Fibonacci extensions.
Swing Trading Strategy:
1. Entry Points:
• Pullback Entry: Enter near $154.65 if the price consolidates or pulls back, with confirmation from bullish candlesticks or volume support.
• Breakout Entry: Enter on a breakout above $171.95 with high volume, signaling the next bullish leg.
2. Stop-Loss Placement:
• For pullback entries, set the stop-loss below $143.15 to limit downside risk.
• For breakout entries, use $154.65 as the trailing stop.
3. Profit Targets:
• Target 1: $190 (first resistance zone based on psychological levels).
• Target 2: $200 (round number and potential next resistance level).
Impact of Stan Druckenmiller’s Position:
• Druckenmiller’s significant increase in his position signals institutional-level confidence in Natera’s future prospects. This move is likely to attract retail and institutional buyers, potentially driving further upside momentum.
• Such institutional confidence aligns with the bullish technical setup, strengthening the case for a swing trade.
Risk Management:
• Allocate a small portion of capital to mitigate risks, particularly in the event of a broader market pullback.
• Monitor for any breaking news or fundamental changes that could impact the stock.
Summary:
Natera Inc. (NTRA) is poised for further upside due to its strong technical momentum and backing from high-profile investors like Stan Druckenmiller. A pullback to $154.65 or a breakout above $171.95 presents attractive entry opportunities for swing traders. Combining technical signals with institutional support makes this stock a compelling candidate for short- to medium-term gains.
Disclaimer:
This analysis is for informational and educational purposes only and should not be considered as financial advice or a recommendation to buy or sell any securities. Stock trading involves substantial risk, and you should perform your own research or consult a financial advisor before making investment decisions. Past performance is not indicative of future results. The information provided herein is based on publicly available data and does not account for your individual financial situation. Trade responsibly.
Natera, Inc.
Uptrend: The stock has been in a strong uptrend, especially since the early part of 2024, as shown by the consistent pattern of higher highs and higher lows. The stock recently bounced back after a brief pullback and is attempting to break the resistance level around the $133.54 mark.
Bollinger Bands: The price is trading near the upper Bollinger Band, which may suggest that the stock is nearing an overbought condition. However, in an uptrend, prices can remain at the upper band for extended periods.
Resistance: The price has faced resistance near the $133.54 level, which is close to its current price. A clean break and close above this level would likely lead to further bullish momentum.
Support: The moving average and lower Bollinger Band near the $120 level provide strong support. Any retracement towards this area may attract buyers.
The volume has been moderate, but the price continues to rise, showing a positive price-volume relationship. There was a notable volume spike in early May, coinciding with a strong upward move, indicating strong buying interest at that time.
Bullish Scenario: If the stock can break above the $133.54 resistance level with strong volume, it could lead to a further rally, pushing prices towards the next psychological level of $140.
Bearish Scenario: If the price fails to break resistance and falls below the moving average and the lower Bollinger Band around $120, the stock may see a correction towards the $105-$110 range.
Overall, the stock is in a solid uptrend, and the breakout above $133.54 could signal further gains. However, traders should be cautious of potential resistance and overbought conditions.
NTRA: Entry, Volume, Target, StopEntry: above 132.01
Volume: above 1.34M
Target: 142.90 area (this is an area, no guarantees, you should be selling on the way up)
Stop: Depending on your risk tolerance; Based on an entry of 132.02, 126.58 gets you 2/1 Reward to Risk Ratio.
This LONG swing trade idea is not trade advice and is strictly based on my ideas and technical analysis. No due diligence or fundamental analysis was performed while evaluating this trade idea. Do not enter a trade based on my idea, do not follow anyone blindly, do your own analysis and due diligence. I am not a professional trader.
Natera a bullish rally(long time)-Crossing the previous roofA preliminary injunction has been granted in favor of Natra in a patent infringement suit. This could be the start of a bullish rally, or it could take until the outcome of NeoGenomics' appeal.
Natera's Resilience Shines Through Patent Battle
In a recent legal showdown, Natera ( NASDAQ:NTRA ) emerged victorious, navigating a complex patent battle with competitor Ravgen that sent its stock soaring to nearly a two-year high. Despite facing a $57 million setback in damages, significantly less than the initial $410 million sought by Ravgen, Natera remains resilient and is set to achieve cash-flow break-even in 2024.
Navigating Legal Waters:
The legal tussle dates back to 2020 when Ravgen accused Natera of infringing on two U.S. patents related to preventing cell lysis. This process, wherein a cell's membrane breaks, poses a challenge for accurate analysis as vital inner content spills out. Ravgen specifically targeted several of Natera's DNA-reading tests, including Panorama, Signatera, and Prospera.
While the jury ruled in favor of Ravgen and awarded $57 million in damages, a mere 14% of the original claim, the silver lining for Natera lies in the fact that the jury found no willful infringement. This decision may safeguard Natera from a substantial increase in damages if an appeal were to fail. Notably, the patents in question have already expired, mitigating the long-term impact on Natera's operations.
Financial Outlook:
Despite the legal setback, Canaccord Genuity analyst Kyle Mikson maintains a positive outlook on Natera, emphasizing that the $57 million payment, if upheld, would likely occur beyond 2024. Mikson suggests that Natera is on track to achieve quarterly free cash flow break-even during 2024, a pivotal milestone for the company's financial health. Natera's ability to generate positive free cash flow of around $3 million in the fourth quarter aligns with its strategic goals.
Strategic Moves and Market Response:
Natera's stock surged 6.5% to $67 following the legal decision, reaching a nearly two-year high. The company's successful litigation against competitors, including wins in minimal residual disease testing against NeoGenomics and Invitae, as well as in transplant testing against CareDx, underscores the strength of Natera's patent portfolio.
Analysts like Mikson emphasize that Natera's patent portfolio is an underappreciated asset, contributing to the company's resilience in the face of legal challenges. The recent breakout of Natera's stock from a cup-with-handle base further signals positive momentum, with a strong IBD Digital Relative Strength Rating of 94, placing it in the top 6% of all stocks based on 12-month performance.
Conclusion:
Natera's ability to weather legal storms and emerge with a manageable settlement showcases the company's resilience and strategic positioning. With a focus on achieving cash-flow break-even in 2024 and a robust patent portfolio, Natera appears well-positioned for future growth and innovation in the competitive DNA-testing industry. Investors and industry observers should keep a close eye on Natera as it continues to navigate challenges and capitalize on opportunities in the evolving healthcare landscape.
RetracedWe've got a retracement in a clear downtrend. Even in the short term this has completed a valid Fibonacci correction.
$NTRA Natera Channel BreakNatera breaking out of a defined channel. Possible target would be gap close around $52,52
$NTRA Natera Look for a channel breakNatera, Inc. is a clinical genetic testing company based in Austin, Texas that specializes in non-invasive, cell-free DNA testing technology, with a focus on women’s health, cancer, and organ health.
Looks like some consolidation in a fixed range from March this year.
A break of $41,60 level would be considered bullish with a possible gap close target of $52.50
Natera (NASDAQ: $NTRA) Going Into Full Breakout Mode! 📈Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify single-gene disorder; Horizon carrier screening to determine carrier status for various genetic diseases; and Spectrum to identify chromosomal anomalies or inherited genetic conditions during an in vitro fertilization cycle. The company also provides Anora miscarriage test products to analyze fetal chromosomes to understand the cause of miscarriage; and non-invasive paternity testing products to determine paternity by gestation using a blood draw from the pregnant mother and alleged father. In addition, it offers Constellation, a cloud-based software product that enables laboratory customers to gain access through the cloud to the company's algorithms and bioinformatics in order to validate and launch tests; Signatera, a circulating tumor DNA technology that screen for a generic set of mutations independent of an individual's tumor; and Prospera used to assess organ transplant rejection. The company offers products through its direct sales force, as well as through a network of approximately 100 laboratory and distribution partners. It has a partnership agreement with BGI Genomics Co., Ltd. to develop, manufacture, and commercialize NGS-based genetic testing assays; and Foundation Medicine, Inc. to develop and commercialize personalized circulating tumor DNA monitoring assays. The company was formerly known as Gene Security Network, Inc. and changed its name to Natera, Inc. in 2012. Natera, Inc. was founded in 2003 and is based in Austin, Texas.
NTRA Weekly LongNASDAQ:NTRA weekly long setup:
Entry above last week's high at 121.25
Stop loss under last week's low at 112.63
Profit target 169.03
Risk/Reward 5.54
NTRA following the trend upNice looking stock to catch with decent momentum and decent fundamentals going forward. Reward to Risk is around 1.55 which keeps good money management.
Paid for NATERA Hello traders, NATERA is at a very important moment in its history, we can witness a new historical high. She is in a bullish momentum with a hammer bull candle and a large a small buy volume at the end of the session. We notice more buying volume than selling but a large volume of sales has passed. In the TIMEFRAME 5 min it is a bullish continuation and on the 1Min it is a buy line so the title still asks to rise. NATERA wants to break the VWAP to find the volume and arrive at half of the range. Very likely to breakout the range and go looking for a new historic high.
Please LIKE & FOLLOW, thank you!
Tight flag formation in NTRADefinitely keeping an eye on this one this week. It looks like it had a couple bounces on the 20ma on 8/4 & 8/11 so it may take 3-4 days for the ma to meet the price.
NTRA close to support!Hi again! This is looking okay. NTRA has had a good pullback. So going long at 47.43 with a target of 49.95!
NTRA - Inverse Head & Shoulders Continuation PatternNTRA putting in a nice 2-month long continuation pattern. Buy on a daily close above the neckline on above average volume.
Natera Announces Achievement of $55 Million In Pharma Contracts NTRA: Natera, Inc.
2020-01-06 08:30:00
Natera Announces Achievement of $55 Million In Pharma Contracts and Issuance of New Oncology Patents
NTRA Long on Ascending ChannelPros:
- Strong uptrend confirmed by SMA lines 20>50>100>150>200
- MACD ticking up
- Force index ticking up and above 0
- Hammer confirmation (suppor retested and tail did not touch support)
Cons:
- Hammer volume is relatively low. Ideally a higher volume on hammer would be prefered. I am currently testing the theory to ignore volume and rely more on force index. It make more sense to rely on price movement + volume to make a decision instead of just volume alone.
- The channel range is not broad enough to target 3R confidently.
Overall Trade Grade: 66.66% (8/12)
Uptrend: 2/2
MACD: 1/2
Force Index: 1/2
RSI: 1/2
Reversal candle: 2/2
Entry timing: 1/2
